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In Brief
Individuals exhibit marked het-
erogeneity in the degree of adi-
posity that results from con-
sumption of an obesogenic diet.
We hypothesized that markers of
inflammation, fecal microbiome,
and/or proteome composition
might associate with heteroge-
neity in diet-induced obesity. We
found the fecal proteome, which
was comprised of microbial pro-
teins that changed markedly
upon exposure to the obeso-
genic diet associated with extent
of obesity and associated dys-
glycemia. These results suggest
the fecal microbial proteome
plays a role in diet-induced
obesity.
Graphical Abstract
Highlights
• Feeding mice a western-style obesogenic diet resulted in dramatic changes in fecal microbial
proteome.
• Basal fecal microbial proteome, but not microbiome, composition was associated with extent of
diet-induced obesity.
• A major feature of fecal microbial proteome of high-responder mice was enriched motility-related
proteins.
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Associations of the Fecal Microbial Proteome
Composition and Proneness to Diet-induced
Obesity*□S
Hao Q. Tran‡, Robert H. Mills§¶**, Nicole V. Peters‡‡, Mary K. Holder‡‡§§,
Geert J. de Vries‡‡, Rob Knight**, Benoit Chassaing‡ ‡‡,
David J. Gonzalez§¶**‡‡‡§§§, and Andrew T. Gewirtz‡ ‡‡‡¶¶
Consumption of refined high-fat, low-fiber diets promotes
development of obesity and its associated conse-
quences. Although genetics play an important role in
dictating susceptibility to such obesogenic diets, mice
with nearly uniform genetics exhibit marked heteroge-
neity in their extent of obesity in response to such diets.
This suggests non-genetic determinants play a role in
diet-induced obesity. Hence, we sought to identify pa-
rameters that predict, and/or correlate with, develop-
ment of obesity in response to an obesogenic diet. We
assayed behavior, metabolic parameters, inflammatory
markers/cytokines, microbiota composition, and the fe-
cal metaproteome, in a cohort of mice (n  50) prior to,
and the 8 weeks following, administration of an obeso-
genic high-fat low-fiber diet. Neither behavioral testing
nor quantitation of inflammatory markers broadly pre-
dicted severity of diet-induced obesity. Although, the
small subset of mice that exhibited basal elevations in
serum IL-6 (n  5) were among the more obese mice in
the cohort. While fecal microbiota composition changed
markedly in response to the obesogenic diet, it lacked
the ability to predict which mice were relative prone or
resistant to obesity. In contrast, fecal metaproteome
analysis revealed functional and taxonomic differences
among the proteins associated with proneness to obe-
sity. Targeted interrogation of microbiota composition
data successfully validated the taxonomic differences
seen in the metaproteome. Although future work will be
needed to determine the breadth of applicability of
these associations to other cohorts of animals and hu-
mans, this study nonetheless highlights the potential
power of gut microbial proteins to predict and perhaps
impact development of obesity. Molecular & Cellular
Proteomics 18: 1864–1879, 2019. DOI: 10.1074/mcp.
RA119.001623.
Obesity is an emerging 21st century epidemic. Obesity, and
the disease states it drives, including type 2 diabetes, cardio-
vascular disease, and liver disease threaten to overwhelm
healthcare systems (1). Thus, obesity is a contemporary med-
ical concern that poses a grave public health crisis in dire
need of a solution. The increased incidence in obesity is
thought to have been driven by broad societal changes that
have resulted in reduced physical activity and increased avail-
ability of palatable low-cost energy-rich foods (2). Yet the
extent to which individuals develop obesity in such an envi-
ronment is highly heterogeneous. Variations in individual ge-
netics contribute to, but are insufficient to fully explain, such
heterogeneity. For example, studies characterizing weight-
discordant monozygotic twins has shown that individuals with
shared environmental, physical activity, and genetic factors
display heterogeneity in adiposity (3). Similarly, rat-based
studies show marked heterogeneity in weight gain and adi-
posity in response to obesogenic diets even when using
highly inbred animals in a well-controlled environment (4, 5).
Better understanding non-genetic factors that influence
proneness to obesity might aid the identification of individuals
at-risk for development of obesity and can yield modifiable
factors to ameliorate this disease state.
Several factors that are at least partially independent of
genetics are proposed to influence proneness to diet-induced
obesity (DIO)1. One potential central nexus of such factors is
inflammation, impacting metabolic signaling pathways includ-
ing insulin and leptin (6), which have well-established roles in
feeding behavior. Inflammation is also suggested to promote
behavioral patterns such as anxiety-like and anti-social be-
haviors that can impact food consumption (7). Although nu-
merous elements impact inflammation, one increasingly ap-
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preciated factor is the gut microbiota (8–12), which is the
collective term for the large diverse community of microor-
ganisms that inhabit the gastrointestinal tract. Indeed, in hu-
mans, gut microbiota composition is associated with obesity.
One way microbiota composition influences metabolic signal-
ing is via lipopolysaccharide (LPS), which activates pro-in-
flammatory signaling via Toll-like receptor 4 (TLR4) resulting in
production of molecules including tumor necrosis factor alpha
(TNF-), and interleukin-6 (IL-6). These molecules interfere
with leptin and insulin signaling, wherein LPS derived from
gamma-proteobacteria is a particularly potent activator of
TLR4 (13). Another host-microbiota interaction implicated in
inflammation and obesity is the sensing of flagella through
TLR5, which keeps motile bacteria in-check by a range of
mechanisms including production of antimicrobial peptides
and promoting production of anti-flagella immunoglobulins
that help regulate the microbiota in the healthy gut (14). In
addition to its impacts on inflammation, microbiota composi-
tion is also reported to influence energy harvest from ingested
food (12, 15). Hence, considering its ability to impact inflam-
mation, metabolism, and behavior, gut microbiota composi-
tion might provide a means of identifying host proneness to
obesity when presented with an obesogenic diet.
Here, we sought to identify microbiota-based markers that
might predict proneness to diet-induced obesity, specifically
exposing mice to a western-style, low-fiber high fat diet
(HFD). Both targeted and untargeted approaches were uti-
lized including 16S rRNA gene amplicon sequencing for mi-
crobial community profiling and a Tandem Mass Tag (TMT)
based multiplexed mass spectrometry (MS) approach for anal-
ysis of the fecal metaproteome. Additionally, we measured be-
havior, inflammatory markers, and metabolic parameters. No-
tably, we show that the fecal metaproteome appears to be a
promising candidate for distinguishing mice with differential re-
sponses to obesogenic diets. Collectively, this study provides
insight into potential mechanisms regarding the host-microbiota
interactions mediating response to HFD exposure and high-
lights putative biomarkers for predicting DIO.
EXPERIMENTAL PROCEDURES
Mice and High-fat Diet Administration—Female, 3–5 week old
C57BL/6 mice were purchased from Jackson Laboratory (Bar Harbor,
ME) and maintained at Georgia State University, Atlanta, Georgia
under institutionally approved protocol under approved protocols
(IACUC # A14033), housed 5 mice per cage, were subjected to
metabolic monitoring, including behavior analysis and sample collec-
tion over a 3-week period. During this time, the mice were fed stand-
ard grain-based chow (GBC), which is comprised of relatively unre-
fined ingredients. The cohort of mice was then switched to a diet
composed of 60% kcal from fat (Research Diet, D12492) for 8 weeks.
Mice were then euthanized, and colon length, colon weight, spleen
weight and adipose weight were measured. Serum, feces, and organs
were collected for downstream analysis.
Fecal Metaproteome Data Acquisition—Fecal samples were meas-
ured out to0.2 g and suspended in 10 ml of ice-cold, sterilized TBS.
A 20 M vacuum, steriflip (Milipore, Burlington, MA) filter was used to
remove particulate from the samples. Cells were pelleted through
centrifugation at 4000 rpm for 10 min. Next, cells were lysed in 2 ml
of buffer containing 75 mM NaCl (Sigma, St. Louis, MO), 3% sodium
dodecyl sulfate (SDS, Fisher, Fair Lawn, NJ), 1 mM NaF (Sigma), 1 mM
beta-glycerophosphate (Sigma), 1 mM sodium orhtovanadate
(Sigma), 10 mM sodium pyrophosphate (Sigma), 1 mM phenylmethyl-
sulfonyl fluoride (PMSF, Sigma), and 1X Complete Mini EDTA free
protease inhibitors (Roche, Indianapolis, IN) in 50 mM HEPES (Sigma),
pH 8.5 (16). An equal volume of 8 M Urea in 50 mM HEPES, pH 8.5 was
added to each sample. Cell lysis was achieved through two 10 s
intervals of probe sonication at 25% amplitude. Proteins were then
reduced with dithiothreitol (DTT, Sigma), alkylated through iodoacet-
amide (Sigma), and quenched as previously described (17). Proteins
were then precipitated via chloroform-methanol precipitation and
protein pellets were dried (18). Protein pellets were re-suspended in 1
M urea in 50 mM HEPES, pH 8.5 and digested overnight at room
temperature with LysC (Wako, Osaka, Japan) (19). A second, 6-hour
digestion using trypsin at 37 °C was performed, and the reaction was
stopped through addition of 10% trifluoroacetic acid (TFA, Pierce,
Waltham, MA). Samples were then desalted through C18 Sep-Paks
(Waters, Milford, MA) and eluted with a 40 and 80% Acetonitrile
solution containing 0.5% acetic acid (20). Concentration of desalted
peptides was determined with a BCA assay (Thermo Scientific, Rock-
ford, IL). Fifty microgram aliquots of each sample were dried in a
speed-vac, additional bridge channels consisting of 25 g from each
sample were created and 50 g aliquots of this solution were used in
duplicate per TMT 10-plex (Thermo Scientific) as previously de-
scribed (21). These bridge channels were used to control for labeling
efficiency, inter-run variation, mixing errors and the heterogeneity
present in each sample (22). Each sample or bridge channel was
resuspended in 30% dry acetonitrile in 200 mM HEPES, pH 8.5 for
TMT labeling with 7 l of the appropriate TMT reagent (23). Reagents
126 and 131 (Thermo Scientific) were used to bridge between mass
spec runs. Remaining reagents were used to label samples in random
order. Labeling was carried out for 1 h at room temperature and
quenched by adding 8 l of 5% hydroxylamine (Sigma). Labeled
samples were acidified by adding 50 l of 1% TFA. After TMT label-
ing, each 10-plex experiment was combined and desalted through
C18 Sep-Paks and dried in a speed-vac. Each 10-plex experiment
was fractionated using a High pH Reversed-Phase Peptide Fraction-
ation Kit (Pierce) per manufacturer instructions. All LC-MS2/MS3 ex-
periments were carried out on an Orbitrap Fusion (Thermo Fisher
Scientific) with an in-line Easy-nLC 1000 (Thermo Fisher Scientific)
and chilled autosampler. Separation and acquisition settings were as
previously defined (24).
Metaproteome Data Processing—Data was processed using Pro-
teome Discoverer 2.1 (Thermo Fisher Scientific). MS2 data was
searched against a catalogue of mouse gut genes (25) (accessed
02/12/2017) containing 2,569,907 entries along side the Uniprot
mouse proteome (www.uniprot.org, access date 11/14/2016) which
contained 53,374 entries. The Sequest searching algorithm (26) was
used to align spectra to database peptides. A precursor mass toler-
ance of 50 ppm (27, 28) was specified and 0.6 Da tolerance for MS2
fragments. Included in the search parameters was static modification
of TMT 10-plex tags on lysine and peptide n-termini (229.162932
1 The abbreviations used are: DIO, diet-induced obesity; CXCL1,
chemokine (C-X-C motif) ligand 1; ELISA, Enzyme-linked immunosor-
bent assay; FliC, flagellin; HEK, human embryotic kidney; IgA, Immu-
noglobulin A; IgG, Immunoglobulin G; IL-6, interleukin 6; Lcn-2, li-
pocalin-2; LPS, lipopolysaccharide; MPO, myeloperoxidase; MRI,
magnetic resonance imaging; TLR4, Toll-like receptor 4; TLR5, Toll
like receptor 5; TNF-, tumor necrosis factor alpha; MS, mass spec-
trometry; TMT, Tandem Mass Tags.
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Da), carbamidomethylation of cysteines (57.02146 Da), and variable
oxidation of methionine (15.99492 Da). The search parameters in-
cluded trypsin as the enzyme used to generate peptides with a
maximum of 2 missed cleavages permitted. A two-step database
search method was utilized (29) wherein proteins identified in either
the forward or reverse database were included in a second search
containing 14,368 entries from the original mouse gut gene catalogue,
and annotations derived from this database were used for down-
stream analysis of microbial proteins (25). A peptide and protein false
discovery rate of 1% was enforced using a reverse database search
strategy (30–32).
TMT reporter ion intensities were extracted from MS3 spectra for
quantitative analysis and signal-to-noise ratios were used for quanti-
tation. Additional stringent filtering was used removing any moderate
confidence peptide spectral matches (PSMs), or ambiguous PSM
assignments. Additionally, any peptides with a spectral interference
above 25% were removed, as well as any peptides with an average
signal to noise ratio less than 10. Normalization occurred as previ-
ously described (24). Briefly, relative abundances are normalized first
to the pooled standards for each protein and then to the median
signal across the pooled standard. An average of these normaliza-
tions was used for the next step. To account for slight differences in
amounts of protein labeled, these values were then normalized to the
median of the entire dataset and reported as final normalized
summed signal-to-noise ratios per protein per sample.
Behavioral Analysis—Three weeks after arrival in the animal facili-
ties, behavior in the open field and in the home cage was assessed in
a counter-balanced fashion over the course of 2 days. Behavioral
testing occurred within the last 4 h of the light and quiescent phase
and was conducted under illumination of overhead white lighting
(between 300 and 400 lux). Open field arenas were cleaned with 70%
ethanol between trials, and home cage bedding was changed after
each trial. Behavioral tests were videotape using a Sony camcorder
for later analysis by The Observer version XT11 (Noldus Information
Technology Inc., Wageningen, The Netherlands). An experiment
blinded as to the treatment conditions scored behavioral tests in the
Observer.
Open Field Test—Locomotor behavior was assessed in a 43.2 X
43.2 X 30.5 cm (WxLxH) Plexiglas arena (Med Associates, Inc., St.
Albans, VT) containing 2 arrays of infrared transmitters strips (16
beams each) located on the bottom of the arena (in the X and Y plane).
The center zone of the arena was defined as square containing the
center 8 beams (e.g. beams 4–12) in the X and Y plane. Each mouse
was placed into the arena with its nose facing the wall and allowed to
freely investigate for 10 min. The total distance traveled, the total time
spent in the center of the arena, and circling behaviors, which are
defined as movements below a preset ambulatory threshold, were
calculated by Activity Monitor (Med Associates, Inc.) on a computer
connected to the open field arenas.
Home Cage Behavior—Mice were placed into a clean housing cage
containing 2 cm deep Alpha-dri bedding (Shepherd Specialty Paper,
Fibercore, Cleveland, OH) and video recorded for 10 min. An exper-
imenter blinded as to condition scored the occurrence and duration of
(1) the time spent walking, as defined by locomotion along the bottom
of the enclosure, around the arena, (2) grooming, as defined by
stroking or scratching the face of body, (3) digging, as defined as
using the fore- or hind paws to displace the bedding, and (4) the rears,
as defined by standing on the hind legs with either the forepaws
unsupported or when the forepaws were supported by the walls of the
enclosure, were quantified using the Observer.
Fasting Blood Glucose Measurement and Body Composition Mea-
surement—For fasting blood glucose tolerance test, mice were fasted
for 5 h, and baseline blood glucose were measured by using a Nova
Max plus Glucose meter and expressed in mg/dL. Measurement of
percent fat mass and lean mass was performed via MRI (Bruker
MiniSpec) at day 0, prior to diet treatment, and day 28 and 56, after
diet treatment.
Fecal Sample Preparation for Immunoglobulin Quantification—Fe-
cal sample preparation of enzyme-linked immunosorbent assay
(ELISA) has been previously described (33). One hundred milligrams
of fecal pellets were homogenized in 3 ml of collection media con-
sisting of 0.05 mg soybean trypsin inhibitor per ml of a 3:1 mixture of
1 PBS and 0.1 M EDTA, pH 7.4. Following centrifugation at 1800
rpm for 10 min, the supernatant was centrifuged again at 14,000 rpm
for 15 min at 4 °C, and final supernatant was collected and stored
with 20% glycerol and 2 mM phenylmethylsulfonyl fluoride (Sigma,
P-7626) at 20 °C until analysis.
Fecal and Serum Anti-flagellin IgA/IgG—Quantification of anti-
flagellin- specific IgA and IgG has been previously described (34–36).
Briefly, 96-well microtiter plates (Costar, Corning, NY) were coated
with 100 ng/well of laboratory-made flagellin in 9.6 pH bicarbonate
buffer overnight at 4 °C. Serum samples from mice were then applied
either pure or at a 1:100 dilution for 1 h at 37 °C. After incubation and
washing, the wells were incubated with either horseradish peroxi-
dase-linked anti-mouse IgG (GE Healthcare Life Sciences, Pittsburgh,
Pennsylvania) or horseradish peroxidase-linked anti-IgA (Southern
Biotech, Birmingham, Alabama). Quantification of immunoglobulin
was then developed by the addition of 3,3,5,5-Tetramethylbenzidine
and the optical density was calculated by the difference between
readings at 450 nm and 540 nm.
Fecal Lcn-2 Quantification—As previously described (37), frozen
fecal samples were reconstituted in PBS containing 0.1% Tween 20
at 100 mg/ml and vortexed for 20 min. The homogenate was then
centrifuged at 12,000 rpm for 10 min at 4 °C. Clear supernatants were
collected and stored at 20 °C until analysis. Lcn-2 levels were
measured in the supernatants using Duoset murine Lcn-2 ELISA kit
(R&D Systems, Minneapolis, MN).
Myeloperoxidase Quantification—Tissue samples were homoge-
nized in 100 mg/ml of 0.5% hexadecyltrimethylammonium bromide
(Sigma, St. Louis, MO) in 50 mM PBS, pH 6.0, as previously described
(37). Following 3 cycles of freeze-thaw at 80 °C and 37 °C, samples
were sonicated and centrifuged at 14,000 rpm for 15 min at 4 °C.
Supernatants were stored at 20 °C until analysis. Myeloperoxidase
(MPO) was assayed in the supernatant by adding 1 mg/ml of diani-
sidine dihydrochloride (Sigma, St. Louis, MO) and 5  104% H2O2
and the change in optical density measured at 450 nm.
Serum CXCL1 and IL-6 Quantification—Serum chemokine (C-X-C
motif) ligand 1 (CXCL1) and Interleukin-6 (IL-6) concentrations were
determined using Duoset cytokine ELISA kits (R&D Systems, Minne-
apolis, MN) according to manufacturer’s instructions (37).
Fecal Flagellin and Lipopolysaccharide Load Quantification—We
quantified flagellin and lipopolysaccharide (LPS) as previously de-
scribed using human embryonic kidney (HEK)-Blue-mTLR5 and HEK-
BluemTLR4 cells, respectively (Invivogen, San Diego, CA) (37, 39). We
resuspended fecal material in PBS to a final concentration of 100
mg/ml and homogenized for 10 s using a Mini-Beadbeater-24 without
the addition of beads to avoid bacteria disruption. We then centri-
fuged the samples at 8000  g for 2 min, serially diluted the resulting
supernatant, and applied to mammalian cells. Purified E. coli flagellin
and LPS (Sigma, St Louis, MO) were used for standard curve deter-
mination using HEK-Blue-mTLR5 and HEK-Blue-mTLR4 cells, re-
spectively. After 24 h of stimulation, we applied cell culture superna-
tant to QUANTI-Blue medium (Invivogen, San Diego, CA) and
measured alkaline phosphatase activity at 620 nm after 30 min.
Microbiota Analysis by 16S rRNA Gene Sequencing Using Illumina
MiSeq Technology—16S rRNA gene amplification and sequencing
were performed using the Illumina MiSeq technology following the
protocol of Earth Microbiome Project with their modifications to the
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MOBIO PowerSoil DNA Isolation Kit procedure for extracting DNA
(www.earthmicrobiome.org/emp-standard-protocols). Bulk DNA were
extracted from frozen extruded feces using a PowerSoil-htp kit from
MoBio Laboratories (Carlsbad, CA) with mechanical disruption (bead-
beating). The 16S rRNA genes, region V4, were PCR amplified from
each sample using a composite forward primer and a reverse primer
containing a unique 12-base barcode, designed using the Golay
error-correcting scheme, which was used to tag PCR products from
respective samples (40). We used the forward primer 515F
5-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTG-
TGCCAGCMGCCGCGGT AA-3: the italicized sequence is the 5
Illumina adapter B, the bold sequence is the primer pad, the italicized
and bold sequence is the primer linker and the underlined sequence
is the conserved bacterial primer 515F. The reverse primer 806R used
was 5-CAAGCAGAAGACGGCATACGAGAT XXXXXXXXXXXX AGT-
CAGTCAG CCGGACTACHVGGGTWTCTAAT-3: the italicized se-
quence is the 3 reverse complement sequence of Illumina adapter,
the 12 X sequence is the golay barcode, the bold sequence is the
primer pad, the italicized and bold sequence is the primer linker and
the underlined sequence is the conserved bacterial primer 806R. PCR
reactions consisted of Hot Master PCR mix (Five Prime), 0.2 M of
each primer, 10–100 ng template, and reaction conditions were 3 min
at 95 °C, followed by 30 cycles of 45 s at 95 °C, 60 s at 50 °C and 90 s
at 72 °C on a Bio-Rad thermocycler. Four independent PCRs were
performed for each sample, combined, purified with Ampure mag-
netic purification beads (Agencourt), and products were visualized by
gel electrophoresis. Products were then quantified (BIOTEK Fluores-
cence Spectrophotometer) using Quant-iT PicoGreen dsDNA assay.
A master DNA pool was generated from the purified products in
equimolar ratios. The pooled products were quantified using Quant-iT
PicoGreen dsDNA assay and then sequenced using an Illumina
MiSeq sequencer (paired-end reads, 2  250 bp) at Cornell Univer-
sity, Ithaca.
16S rRNA Gene Sequence Analysis—Forward and reverse Illumina
reads were joined using the fastq-join method (41, 42), sequences
were demultiplexed, quality filtered using Quantitative Insights Into
Microbial Ecology (QIIME, version 1.8.0) software package (43).
QIIME default parameters were used for quality filtering (reads trun-
cated at first low-quality base and excluded if: (1) there were more
than three consecutive low quality base calls (2), less than 75% of
read length was consecutive high quality base calls (3), at least one
uncalled base was present (4), more than 1.5 errors were present in
the bar code (5), any Phred qualities were below 20, or (6) the length
was less than 75 bases). Sequences were clustered to operational
taxonomic units (OTUs) using UCLUST algorithm (44) with a 97%
threshold of pairwise identity (without the creation of new clusters
with sequences that do not match the reference sequences), and
taxonomically classified using the Greengenes reference database
13_8 (45). A single representative sequence for each OTU was aligned
and a phylogenetic tree was built using FastTree (46). The phyloge-
netic tree was used for computing the unweighted UniFrac distances
between samples (47, 48), rarefaction was performed and used to
compare abundances of OTUs across samples. Principal coordinates
analysis (PCoA) plots were used to assess the variation between
experimental group (beta diversity). Alpha diversity curves were de-
termined for all samples using the determination of the number of
observed species. LEfSE (LDA Effect Size) was used to investigate
bacterial members that drive differences between groups (49). Un-
processed sequencing data are deposited in the European Nucleo-
tide Archive under accession number PRJEB33328.
Experimental Design and Statistical Rationale
Study Design—The overall study included 50 mice which were
followed longitudinally for monitoring of weight gain and other meas-
ures. The sample size was determined for statistical power based on
previous publications (4, 5) and experience. The metaproteome anal-
ysis included four mice with the highest weight gain and the lowest
weight gain. These samples sizes were determined to be enough
based on previous reports of strong differences in related animal
models with similar sample sizes (50).
Metaproteome Analysis—Metaproteome analysis was performed
using python (version 3.5) and records are available online (https://
github.com/rhmills/High-Fat_Diet_Metaproteomics_analysis). Extra
files associated with the analysis within the notebooks are deposited
as supplementary files in the MassIVE (https://massive.ucsd.edu) re-
pository for this study (Study ID: MSV000083891). All analysis was
performed on the proteins identified in both TMT 10-plex experi-
ments. Qiime2, version 2019.1 (https://qiime2.org/), was used for
principle coordinates analysis through the command “qiime diversity
core-metrics” as well as for determining significance of beta-diversity
clustering through the command “qiime diversity beta-group-signifi-
cance.” K-means clustering was performed through Morpheus
(https://software.broadinstitute.org/morpheus). Enriched and de-
pleted proteins were determined by –score, which accounts for
both fold change and p value (51). A statistical cutoff for highly ranked
associations was set to   1 (  0.05), which provided an
adequate number of proteins for functional and taxonomic assess-
ment (52) while maintaining a moderate stringency. Volcano plots
were visualized using GraphPad Prism (version 7.0b). Mouse protein
gene functional enrichment analysis was performed using DAVID (53),
with all mouse proteins identified as a background list. The python
package, Seaborn (version 0.9.0) was used for boxplots, swarmplots,
and catplots. Statistical analysis between groups within the boxplots
was performed using ANOVA with Dunnett corrected p values
through GraphPad Prism (version 7.0b).
Statistical Analysis—Significance was determined using unpaired
two-tailed t test or linear regression analysis (GraphPad Prism soft-
ware, version 6.01). Differences were noted as significant *p  0.05
for t test or linear regression analysis. For clustering analyzing on
principal coordinate plots, categories were compared, and statistical
significance of clustering was determined via Permanova (54).
RESULTS
Stratification and Characterization of Mice Prone, or Resist-
ant, to HFD-induced Metabolic Syndrome—The primary goal
of this study was to elucidate factors that predict and possibly
govern, susceptibility to developing obesity in response to
administration of an obesogenic diet. Hence, we designed a
prospective study wherein 50, 3-week-old female C57BL/6
mice, housed 5 mice per cage, were subjected to metabolic
monitoring, including behavior analysis and sample collection
over a 3-week period. During this time, the mice were fed
standard grain-based chow (GBC), which is comprised of
relatively unrefined ingredients. The cohort of mice was then
switched to a diet compositionally low in fiber (5%) and high
in fat (35% by mass, 60% by calories), herein referred to as an
obesogenic diet or high-fat diet (HFD) for an 8-week period.
Prior to, during and after administration of the high-fat diet,
sample collection and monitoring was performed as outlined
in Fig. 1A. In accord with our previous rodent-based studies
(5), the extent of obesity following the obesogenic diet was
quite heterogeneous with many mice weighing between
20–25 grams, which is the approximate weight of age-
matched GBC-fed mice of this strain/gender. In contrast,
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some mice appeared to dramatically gain weight over the
course of the experiment with final weights over 30 grams.
Therefore, based on their final body weight, mice were strat-
ified into tertiles as being prone, intermediate, or relatively
resistant to being obese following exposure to an obesogenic
diet (Fig. 1B). First, we examined if mice prone or resistant to
DIO clustered within cages but did not observe a distribution
pattern to support this possibility (Fig. 1C). Nor were these
groupings significantly related to the initial weight of the mice
(Fig. 1D). The total weight gain over the period of exposure to
the obesogenic diet for resistant mice was about 40%. This
observation is approximately the expected age-related weight
FIG. 1. Stratification and characterization of mice prone, or resistant, to HFD-induced metabolic syndrome. A, 3–5-week old, female
C57BL/6 mice were purchased from The Jackson Laboratory and housed for 3 weeks before high-fat diet administration in order to favor
microbiota stabilization. Subsequently, animals were treated with high-fat diet (60% kcal from fat) for 8 weeks. Serum collection occurred on
days 7, 0, and 56. Body weight measurements occurred prior to every flagellin administration. Fecal collection occurred on days 21 and
7, then every other week starting on day 0. B, Mice were identified as low, intermediate, or high responders based on if their final body weight
fell within the first, second, or third tertile, respectively. C, Final body weights of mice by cage. D, Initial weights of mice. E, Body weights were
measured weekly and expressed as relative values, day 0 (pre high-fat diet treatment) being defined as 100%. Final body weights were
correlated to (F) fat mass by MRI, G, epididymal adipose weight, H, day 56 fasting blood glucose, and I, colon weight/length ratio. Data are
the means  S.E. (n 	 50). Significance was determined using linear regression analysis (*p  0.05).
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gain of GBC-fed mice during this period, whereas prone mice
increased in weight by about 70% during this period (Fig. 1E).
Fat mass, as determined by magnetic resonance imaging
(MRI), prior to, during, or at the end of exposure to HFD, was
highly correlated with body weight within the cohort (Fig. 1F).
Accordingly, post-euthanasia weight of the periovarian fat
pad, which has classically been used to assess adiposity in
mice correlated closely (r2 	 0.8229) with final body weights
confirming our stratifications reflected degree of adiposity
(Fig. 1G). Final body weights were also correlated with fasting
glucose concentration (r2 	 0.2218), suggesting mice that
were prone to diet-induced obesity were also prone to its
downstream consequences (Fig. 1H). Last, considering the
appreciation that low-grade intestinal inflammation can pro-
mote adiposity and its consequences, we measured weight/
length ratio of the colon (55, 56). This measurement was also
correlated with final body weight (r2 	 0.2781; Fig. 1I), sup-
porting the notion that the obese mice were in a state of
low-grade gut inflammation.
Associations of Inflammatory Markers/Mediators and
Proneness to Obesity—Low-grade inflammation is reported
to associate with, and promote obesity (56, 57). Accord-
ingly, we investigated levels of pro-inflammatory mediators
to determine if they might mark mice that would be prone to
becoming obese following exposure to an obesogenic diet.
Hence, we measured levels of fecal lipocalin-2 (Lcn-2),
which is a broadly dynamic marker of gut inflammation (37).
Levels of fecal Lcn-2 did not correlate with final body
weights when measured 14 days prior (r2 	 0.0156) to
exposure or 4 weeks after the initiation of the diet (r2 	
0.0074; Fig. 2A, 2B). Additionally, the levels of serum pro-
inflammatory cytokines CXCL1 and IL-6 when measured 7
days prior to administration of the obesogenic diet were
also not correlated to final body weight (r2 	 0.0177, 0.022
respectively, Fig. 2C, 2D). However, 4 of the 5 mice that
displayed detectable serum IL-6 at this time point were in
the top tertile of obesity following the diet suggesting the
subset of mice displaying this parameter might be more
prone to DIO. To further investigate this subset of mice, we
tested for differences within various parameters associated
with diet-induced obesity between the subsets of mice with
or without detectable IL-6. At day 7, several of these
parameters were consistent with the possibility that detec-
tion of IL-6 can discriminate high or low responders, but
ultimately, none reached statistical significance (supple-
mental Fig. S1). Nevertheless, such elevations in IL-6 were
not maintained when assayed after 8-weeks of diet (Fig. 2E).
Other findings supporting the notion that obesity is associ-
ated with low-grade inflammation included a modest corre-
lation after 8-weeks of diet between body weights and
CXCL1, which is a chemokine expressed by many cell types
and often used as a general serum marker of low-grade
inflammation (r2	 0.0352, Fig. 2F). In contrast, there was no
correlation between final body weights and levels of intes-
tinal myeloperoxidase (MPO), which is a widely used marker
of classic inflammation in the intestine (58) (Fig. 2G).
Gut bacterial components, flagellin and lipopolysaccharide
(LPS), are well known for their inflammatory properties (59,
60). Fecal levels of each were measured 3 weeks prior to
administration of the obesogenic diet with neither correlating
with final body weight (Fig. 2H, 2I). However, flagellin, but not
LPS, were modestly correlated with final body weight when
measured 4 weeks following initiation of the obesogenic diet
(r2 	 0.0984, 0.0151 respectively, Fig. 2J, 2K). Moreover,
there was a correlation in levels of anti-flagellin antibodies at
the time of diet administration (for IgG but not IgA) and 8
weeks following exposure to obesogenic diet (Fig. 2L–2O).
Levels of anti-flagellin antibodies likely reflect exposure of the
immune system to this molecule, which can be influenced by
both levels of flagellin in the gut, bacterial-epithelial distance,
and intestinal permeability (35, 61). Together, these studies
did not reveal a reliable predictive marker of proneness to
diet-induced obesity but suggest exposure to bacterial prod-
ucts, such as flagellin, might have some predictive power.
Quantitative Measures of Behavior Did Not Predict Obesity
Proneness—The gut-brain axis is increasingly appreciated to
play a role in the pathogenesis of many neurological and
metabolic diseases (62). Hence, we investigated the extent to
which certain behavioral parameters are able to predict
proneness to weight gain. Compulsive behavior and activity
level were measured in a home cage behavior test, and time
spent digging (supplemental Fig. S2A), time spent grooming
(supplemental Fig. S2B), and total distance traveled (supple-
mental Fig. S2C) were quantified. Additionally, anxiety-like
behavior was assessed using the open field test, represented
by time spent in the center zone (supplemental Fig. S2D) and
distance traveled in the center (supplemental Fig. S2E) of the
open field arena. Ultimately, none of these measures had a
significant ability to predict extent of obesity in response to
the obesogenic diet.
Impact of DIO on Fecal Metaproteome—We next turned to
a contemporary metaproteomics approach to study the fecal
protein composition of our cohort of mice. Although admin-
istration of an obesogenic diet is well known to rapidly alter
gut microbiota species composition (63), whether it might also
impact the fecal metaproteome, let alone whether the fecal
metaproteome might predict responsiveness to such a diet,
has not been described. Although metaproteomic analysis
presents the challenges of discriminating host and bacterial
proteins from potentially millions of proteins, the field is an
area of rapid growth currently developing standard method-
ology (64).
To this end, we applied our recently developed TMT-based
metaproteomic methods (52), in combination with a two-step
database search method (29) on feces from mice that devel-
oped the highest and lowest degree of obesity (n	 4 mice per
condition). Our analysis included specimens collected before
(day 0) and after 56 days of exposure to the obesogenic diet.
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FIG. 2. Associations of inflammatory markers/mediators and proneness to obesity. Final body weights correlated to fecal lipocalin-2 at
(A) day14 and (B) 28, analyzed using ELISA kits. Additionally, final body weights were correlated to serum cytokines CXCL1 and IL-6 at (C–D)
day 7 and (E–F) day 56, analyzed using ELISA kits. Final body weights were also correlated to (G) colonic myeloperoxidase levels, as well
as, fecal flagellin and lipopolysaccharide at (H–I) day 21 and (J–K) day 28 using HEK 293 cells expressing mTLR5 or mTLR4 measuring
bioactive flagellin and lipopolysaccharide, respectively. Serum anti-flagellin IgG and IgA were also quantified using ELISA techniques at days
0 (L–M) and 56 (N–O). (n 	 50). Significance was determined using linear regression analysis (*p  0.005).
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The final data included quantitation of 13,975 proteins of
which 1,108 were derived from mice (supplemental Table S1).
For a broad scale perspective of the data, an unsupervised
Principle Coordinates analysis of the metaproteome data us-
ing the Bray-Curtis distance metric exhibited clear separation
of samples before and after diet administration, reflecting a
dramatic impact of the obesogenic diet on the overall fecal
metaproteome (Fig. 3A). This analysis also exhibited cluster-
ing at the 56-day time point discriminating high and low
response to diet (Permanova pseudo-F 	 1.99, p 	 0.058).
Using K-means clustering, we identified 6 protein clusters,
some of which were associated with increased representation
of taxa and functions (Fig. 3B). These groupings include
Group 4, which appeared to show an increased presence of
Clostridiales and lipid transport and metabolism proteins in
high responder mice after exposure to HFD (Fig. 3B). These
groupings provide putative taxonomic associations to the
functional differences observed before and after administra-
tion of HFD.
Comparing all samples before and after HFD exposure
made evident that there were widespread changes in the fecal
metaproteome. By using a statistical ranking method ac-
counting for both fold change and t test p values, -score
(51), we observed that 58% (3670/6311) of proteins displayed
a high level of association to diet exposure (   1, Fig. 3C).
The proteins associated with the dietary intervention con-
tained large differences in their taxonomic and functional
annotations. Taxonomic differences included a larger portion
of proteins from Clostridiales and Bacteroidales before HFD
exposure whereas a large portion (40%) of proteins en-
riched after 8-weeks exposure were derived from Lactobacil-
lales (Fig. 3D).
Functional categorization of the proteins associated to the
dietary intervention was performed through the Evolutionary
Genealogy of Genes: Non-supervised Orthologous Groups
(eggNOG) database. These studies revealed a very strong
association between proteins related to motility and HFD
exposure as expression levels of 141 proteins were reduced
following exposure to HFD with only 3 proteins increased after
HFD, resulting in a 32-fold difference (Fig. 3E). In accord, we
note that, on average, levels of fecal flagellin decreased by
about 5-fold when measured 21 days preceding or 4 weeks
following administration of the obesogenic diet (Fig. 2H, 2J).
Further, when subsetting all 680 flagellin proteins from the
metaproteome dataset, we observed statistically significant
decreases in abundance for both high and low responding
mice (p
 0.0001; supplemental Fig. S3A). Functional assess-
ment of the proteins enriched after HFD exposure resulted in
weaker associations, the strongest of which was a 1.5-fold
increased representation of Transcription proteins (Fig. 3E).
Functional and Taxonomic Characterization of Fecal Meta-
proteome in Low- and High-responder Mice Fed the Obeso-
genic Diet—We next focused the analysis on discovering
patterns in the fecal metaproteome that might have preceded
or accompanied degree of responsiveness to the obesogenic
diet. Toward this end, we examined the broad-scale func-
tional composition of each sample’s metaproteome through
the eggNOG database. This revealed only modest variance
among the samples (Fig. 4A). In contrast, viewing the com-
position of taxonomic orders in this manner revealed differ-
ences, both preceding and following diet exposure, that as-
sociated with a high- and low-response to the diet (Fig. 4B).
There were 424 highly ranked proteins (   1) differentiating
high and low responders at the initial time point (Fig. 4C).
These proteins had large differences in their taxonomic origins
with all proteins distinguishing the low responders belonging
to Clostridiales whereas high responders had over 50% of
proteins derived from Bacteroidales and Lactobacillales (Fig.
4D). Functionally, the proteins distinguishing high responders
had a 14-fold enrichment in “Post-translational modification,
protein turnover, and chaperones” proteins, and a 5.6-fold
enrichment in “Cell motility” proteins (Fig. 4E). Many of the
posttranslational modification, protein turnover, and chaper-
one proteins with the largest differences between high and
low responders were chaperone proteins (supplemental Fig.
S3B), a potential indication of a microbial stress response.
The increased representation of cell motility proteins was a
result of a subset of flagella, mostly derived from the order
Clostridiales, that were significantly increased in high re-
sponders (p 
 0.0001; supplemental Fig. S3C).
We also noted unique sets of carbohydrate metabolism and
transport proteins differentially expressed at the initial time
point. High responders had increased expression of Bacte-
roidale metabolism proteins including isomerases, kinases
and aldolases, whereas Clostridiales uniquely had an in-
creased expression of sugar transporters within low respond-
ers (supplemental Fig. S3D). This could be an indication of
unique energy harvesting capacities in the microbiome pres-
ent before the onset of HFD treatment (12).
In the samples collected following administration of the
obesogenic diet, there were 970 proteins distinguishing high
and low responders (Fig. 4F). In contrast to proteins discrim-
FIG. 3. Impact of DIO on fecal metaproteome. A, Principal coordinates analysis (PCoA) of metaproteome data using the Bray-Curtis
distance metric B, Protein relative abundance heatmap. Samples are clustered by 1-Pearson correlation and proteins are grouped using
KMeans clustering. Relative abundances per protein are colored on a spectrum with red as row maxima and blue as row minima. Functional
and taxonomic bias within each KMeans cluster is displayed on the right. C, Volcano plot of metaproteome response to HFD. Fold change and
t test significance of each protein are plotted. Overall significance was set at -score  1. D, Taxonomic composition of significant proteins.
E, Functional bias in significant proteins. Compositions of eggNOG annotations between proteins enriched in the final and initial time points
were compared and the log ratio of high abundance categories (10 proteins) is shown. Sample names in (A–B) are annotated H for High
Responder, L for Low Responder, then I for Initial time point, F for Final time point, with 1, 2, 3, or 4 for replicate number.
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inating responses at the onset of HFD exposure, the proteins
corresponding to high response were derived entirely from
Clostridiales, whereas nearly 60% of proteins in low respond-
ers were derived from Lactobacillales (Fig. 4G). Changes fol-
lowing the obesogenic diet associated with a high response to
the diet included an 11-fold increased representation of lipid
transport and metabolism proteins (Fig. 4H). It is possible that
the increase in lipid metabolism proteins from Clostridiales
mediates more efficient harvesting of energy from lipids in
high responding mice.
Analysis of Fecal Mouse Proteins—In addition to analyzing
microbial proteins from the metaproteome, we next subset
the data to determine associations within the fecal mouse
proteome. In total, 699 host proteins were quantified within all
samples and therefore included in the statistical analyses. A
large portion (77%) of mouse proteins were strongly influ-
enced by HFD exposure, and 92% of those proteins were
increased after HFD (Fig. 5A). Using DAVID functional enrich-
ment (53), we identified significant (Bonferroni adjusted p
values 
 0.05) enrichment of digestion and myosin proteins
FIG. 4. Functional and taxonomic characterization of fecal metaproteome in low- and high-responder mice fed the obesogenic diet.
A, Functional Composition. B, Taxonomic Composition. C–E, Comparison of significant proteins from high and low responders at the initial
time point. C, Volcano plot displaying the fold change and t test significance of each protein in the metaproteome. Significance was set at
-score  1. D, Taxonomic composition of significant proteins. E, Barplots demonstrating the functional bias in significant proteins.
Compositions of eggNOG annotations were compared between high and low responders and the log ratios of the high abundance categories
(10 proteins) are shown. F–H, Comparison of significant proteins from high and low responders at the final time point. Same analysis as (C–E)
for the final time point. Sample names in (A–B) are annotated H for High Responder, L for Low Responder, then I for Initial time point, F for
Final time point, with 1, 2, 3, or 4 for replicate number.
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before HFD treatment and mitochondrial proteins after HFD
(supplemental Table S2). Notably, myosin proteins occupied 6
of the top 10 proteins associated with the initial samples (Fig.
5B). Phosphorylated myosin light chains have previously been
linked to intestinal permeability after HFD exposure (5). Thus,
our observed decrease in heavy chain myosin proteins may
be related to changes in intestinal permeability. Regarding the
increase of mitochondrial proteins, it was shown that HFD
results in mitochondrial dysfunction (65), and our data likely
reflects this phenomena.
We next looked for mouse fecal proteins that might discrim-
inate high and low responders prior to HFD administration.
Here, 109 mouse proteins strongly differed between the
groups, all of which were enriched in the DIO prone mice (Fig.
5C). Of these proteins, 40 (37%) were related to immunoglob-
ulin. This strong enrichment for immunoglobulin genes was
confirmed through DAVID, which showed a significant, 3-fold
enrichment (Bonferroni p value 	 7.0E-11) for Immunoglobu-
lin V-set proteins (supplemental Table S2). This enrichment of
immunoglobulin variable domains was also illustrated in the
top 20 proteins associated with a heightened response to
HFD (Fig. 5D). These findings further illustrate the link be-
tween low-grade inflammation and DIO, as this is a potential
indication of increased immune activity in high responder
mice, before administration of HFD.
Applying the same analysis to samples collected after
8-weeks exposure to HFD also revealed interesting insight
into proneness to HFD exposure. After the dietary interven-
tion, 63 mouse proteins were highly ranked in their ability to
discriminate between high and low responders. All but two of
these proteins were enriched within the low responders (Fig.
5E). Functional analysis showed a significant 6-fold enrich-
ment (Bonferroni p value 	 4.0E-8) for keratin within the
proteins enriched within low responders (supplemental Table
S2). This increase of keratin could be an indication of greater
colonic stress (66) in low responders at the final time point.
High responders at this time had several immunoglobulin
proteins within the top discriminatory proteins, though most
were only modestly associated (Fig. 5F). Of note, many of the
immunoglobulin proteins were among the strongest discrim-
inatory proteins in high responders at both the initial and final
day.
Analysis of Microbiota Composition Versus Proneness and
Severity to DIO—Last, we examined the potential of fecal
microbiota composition, as analyzed by 16S rRNA gene se-
quencing to identify and/or reflect proneness to DIO. Visual-
FIG. 5. Analysis of mouse fecal proteome. After sub-setting the mouse derived proteins from the metaproteome data, differentially
expressed proteins were determined using a statistical cut-off of -score  1. Volcano plots are shown demonstrating the log2 fold change
(x axis) and log10 p value (y axis) for (A) differences between final and initial samples, (C) differences between high and low responders at the
initial time point, and (E) differences between high and low responders at the final time point. The -score of the most significant proteins from
each analysis are shown below each volcano plot in bar plots (B, D, F).
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ization of fecal microbiota composition of all 50 mice at all
time points by unweighted UniFrac revealed the expected
dramatic difference in microbiota composition before and
following administration of the obesogenic diet (p 	 0.001;
Fig. 6A). This analysis also showed clear, but much more
modest differences between the 5 and 8-week post-dietary
change time points (Fig. 6A). In contrast, using this approach
to examine differences in beta diversity did not identify differ-
ences in microbiota composition in high or low-responders
either prior to (p 	 0.977; Fig. 6B), or following administration
of the obesogenic diet (p 	 0.323; Fig. 6C). Rather, in accord
with other diets, 8-week administration of the diet, which
provided mice an additional 8 weeks to share their microbiota
with their cage-mates, we observed strong cage clustering of
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FIG. 6. Analysis of microbiota composition versus proneness and severity to DIO. Fecal microbiota composition was analyzed using
Illumina sequencing of the V4 region of 16S rRNA genes. Principal coordinates analysis (PCoA) was performed using the unweighted UniFrac
distance metric (A) over the course of HFD administration, B, day 0, C–D day 56. Final body weights were correlated to alpha diversity at (E)
day 0 and (F) day 56. Final body weights were correlated to bacterial groups found at the start of HFD administration: (G) Clostridiales, (H)
Coriobacteriaceae, and (I) Bacteroidales. Final body weights were also correlated to bacterial groups found at the end of HFD administration:
(J) Bacteroidales and (K) Campylobacterales. (n 	 50). In A–D, categories were compared and statistical significance of clustering were
determined via Permanova. In E–K, significance was determined using linear regression analysis (*p  0.005).
Seeking Predictors of Susceptibility to Obesity
Molecular & Cellular Proteomics 18.9 1875
microbiota compositions (p 	 0.001; Fig. 6D). Nonetheless,
levels of alpha-diversity, prior to administration of the obeso-
genic diet were moderately but significantly correlated (r2 	
0.0873, p 	 0.0394) with final body weights (Fig. 6E) suggest-
ing that microbial community structure had some ability to
predict proneness to DIO. An analogous but not significant
trend was observed 8-weeks post-dietary change (Fig. 6F).
That overall assessment of microbiota composition lacked
ability to identify high- and low- responder mice does not
preclude the possibility that select OTUs might provide such
power. Hence, we selected specific OTUs whose abundance
was enriched or depleted at time 0 in the mice that developed
the greatest degree of obesity in response to HFD. This
yielded an array of bacterial groups, those of which had the
ten lowest p values represented here, supplemental Fig. S4.
However, determining whether these differences are repro-
ducible and/or biologically significant will require further ex-
perimentation. Additionally, we examined the ability of bacte-
rial candidates generated by the metaproteomic analysis to
predict (day 0), or reflect (day 56), proneness to the obeso-
genic diet. Of the 12 taxa analyzed in the day 0, 3 groups
showed correlations predicted by the proteomic analysis with
p values lower than 0.1 (Fig. 6G–6I) whereas 9 did not (sup-
plemental Fig. S5A–S5I). Regarding the taxa proteomic anal-
ysis identified as correlating with extent of obesity in the day
56 samples, 2 taxa correlated as determined with p values
lower than 0.1 (Fig. 6J–6K) whereas the 10 others analyzed
did not meet this criteria (supplemental Fig. S6A–S6J). Thus,
overall, although development of approaches to predict
proneness to obesity via analysis of the fecal proteome and/or
microbiome remains a work in progress, these findings sup-
port its potential to contribute to such prognostications.
DISCUSSION
The goal of this study was to improve understanding of
non-genetic determinants of DIO, focusing on parameters
that might be impacted by gut microbiota, which is known to
play a role in dictating severity of DIO. As obesity is promoted
by low-grade, systemic inflammation, which can be driven by
exposure to microbiota products (5), we hypothesized that
inflammatory and microbial factors might impact behavior
and/or metabolism and thereby predict the extent of DIO
displayed by individual hosts. However, the behavioral meas-
ures of general activity and anxiety in 6–8 week old mice were
not predictive of susceptibility to HFD-induced obesity
whereas the inflammatory markers IL-6, MPO, CXCL1, and
LCN-2 showed only very limited ability in discriminating
proneness to DIO when measured before, during, or after
administration of HFD. From a microbial perspective, research
has shown roles for LPS and flagellin in inflammation and
obesity (14, 67, 68). However, although measuring flagellin
levels showed promise for predicting weight after administra-
tion of HFD, it was less successful prior to administration. Our
results revealed new evidence of host-microbial interactions
underlying differential weight gain.
To find microbial factors that may correlate to DIO, we next
turned to an untargeted metaproteomic approach. Our results
confirm prior research showing large shifts in the overall
structure of the metaproteome after administering HFD (50).
These broad shifts seem to be driven by proteins derived from
Clostridiales and Bacteroidales, which decreased upon expo-
sure to HFD, whereas the composition of Lactobacillales pro-
teins expands. Interestingly, this difference was not observ-
able in our analysis of the microbiota by 16S sequencing. One
possible explanation is the known discrepency between
genomic and proteomic technologies (52) which is supported
by the notion that differences in protein abundance are not
directly associated with species composition because of
complex regulatory processes. However, other DNA se-
quence-based studies have also shown significant alterations
in Clostridiales and Bacteroidales upon exposure to HFD (5,
69), further suggesting a role for these taxonomies in HFD
response.
Functionally, the most striking shift with HFD was the de-
creased abundance of flagella after administration of HFD.
Flagellin proteins can be targeted in several ways by the host,
including the release of anti-flagellin IgA and anti-flagellin IgG.
The levels of Anti-flagellin IgA are anti-correlated with total
flagellin load and are a key mechanism for down regulating
motility-related genes (14). Although the overall levels of anti-
flagellin IgG and IgA in general did not significantly correlate
with the obesogenic outcomes, we did see a distinct immune
signature within the fecal proteome of the high responder
mice. This data may suggest that the mice that gain the most
weight have a baseline immune reaction occurring before
treatment. Possible antigens of this immune reaction were
also identified from the metaproteome data including a subset
of flagellin proteins that effectively discriminate high and low
responders. However, as most of the identified immunoglob-
ulin subunit regions could be a result of either IgA or IgV (70),
it is not clear whether this potential reaction is mediated
through TLR5, NOD-like receptor 4, or other mechanisms (67).
Taxonomic differences were also consistent with the idea
that flagellin directed immunoglobulin may be shaping the gut
of high responders before the onset of HFD. The majority of
flagellin proteins identified were derived from Clostridiales,
and Bacteroidales do not contain flagella (71). Here we ob-
served a dominance of Clostridiales proteins enriched in low
responders at the onset whereas Bacteroidales proteins con-
tained a large portion of the high responder metaproteome. If
the observed immunoglobulin proteins from the metapro-
teome were targeting flagella, it may be expected that the
portion of Clostridiales proteins would be shifted in favor of
Bacteroidales.
In total, our results suggest the ability of host and microbial
proteomics to discern subjects particularly prone to develop-
ing DIO. Our results indicated significant metaproteome dif-
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ferences between high and low responding mice despite the
limited number of samples analyzed. In addition, the taxo-
nomic origins and functional roles of these discriminatory
proteins suggested new evidence that host-microbiota inter-
actions may be underlying proneness to DIO. Although larger
studies are needed to confirm our results, the fecal metapro-
teome appears to be a promising tool for identifying hosts at
risk of weight gain upon exposure to an obesogenic diet.
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